Meeting
2018 ASCO Quality Care Symposium
Methods for alerting clinicians to concerning symptom questionnaire responses during cancer care: Approaches from two randomized trials (STAR, AFT-39 PRO-TECT).
Authors
Angela M. Stover
University of North Carolina, Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Angela M. Stover, Sydney Henson, Allison Mary Deal, Carrie Tompkins Stricker, Karen Joan Hammelef, Antonia Vickery Bennett, Philip M Carr, Jennifer Jansen, Lisa A. Kottschade, Amylou C. Dueck, Ethan M. Basch
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Big Data Studies; Projects Relating to Equity, Value, and Policy
Track
Projects Relating to Equity, Value and Policy,Big Data Studies
Sub Track
Integrating Patient Experience Assessment and Patient Reported Outcomes into Practice
Clinical Trial Registration Number
NCT03249090
Citation
J Clin Oncol 36, 2018 (suppl 30; abstr 158)
DOI
10.1200/JCO.2018.36.30_suppl.158
Abstract #
158
Poster Bd #
B12
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Prognostic value of patient reported outcomes (PROs) in advanced gastroesophageal cancer (GO): A systematic review.
First Author: Sayeda Kamrun Naher
Poster
2023 ASCO Quality Care Symposium
Patient-reported outcomes (PROs) in patients (pts) with primary advanced or recurrent endometrial cancer (pA/rEC) treated with dostarlimab (D) plus carboplatin/paclitaxel (CP) compared with CP in the ENGOT-EN6/GOG3031/RUBY trial.
First Author: Mansoor Raza Mirza
Poster
2023 ASCO Annual Meeting
Health related quality of life (HRQoL) in patients with triple-class-exposed relapsed/refractory multiple myeloma (TCE RRMM) treated with idecabtagene vicleucel (ide-cel) versus standard regimens: Patient-reported outcomes (PROs) from KarMMa-3 phase 3 randomized controlled trial (RCT).
First Author: Michel Delforge
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers.
First Author: Xin Shelley Wang